Compare Exenatide (evidence A) and Semaglutide (evidence A) on mechanism, clinical status, safety, and dosing.
Exenatide is a 39-amino-acid GLP-1 receptor agonist (MW ~4186.6 g/mol) originally derived from exendin-4, a peptide found in the saliva of the Gila monster…
Semaglutide is an FDA-approved GLP-1 receptor agonist (MW ~4113.6 g/mol, molecular formula C187H291N45O59) with 94% sequence homology to human GLP-1. It is…
Full profiles: Exenatide, Semaglutide.